Fundraising Fox
/Companies
Sign in

Afynia

3 known investors

Find your way into Afynia

Sign up to see every warm intro you have to Afynia

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Afynia team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Afynia develops diagnostic tools focused on women's health, with an emphasis on endometriosis detection through diagnostic biomarkers. The company operates a CLIA laboratory and works on molecular biology testing for reproductive health conditions.

BiotechDigital HealthFemTechMedical Devices

Founders & leadership

DLDr. Lauren Foster
Dr. Lauren FosterCo-Founder, Chief Executive Officer
DJDr. Jocelyn Wessels
Dr. Jocelyn WesselsCo-Founder, Chief Scientific Officer
W(Warren (Lauren) Foster, Ph.D., FCAHS
Warren (Lauren) Foster, Ph.D., FCAHSCo-Founder, President & CEOCo-Founder & CEO, Afynia
DJDr. Jake Prigoff
Dr. Jake PrigoffChief Medical Officer
DFDarren Farry
Darren FarryChief Financial Officer

Investors · 3

Gaingelslisted by GaingelsNew York · $200K – $500K

How we know: funding news · gaingels.com · Not right? Tell us

Impact America Fundlisted by Impact America FundIrvine · $250K – $3M

How we know: Impact America Fund's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 3

Affinia TherapeuticsAffinia Therapeutics develops genetically engineered adeno-associated virus (AAV) therapies for treating genetic diseases, focusing initially on cardiovascular and central nervous system conditions. The company uses AI and structural modeling to redesign viral delivery vectors for one-time-dose genetic medicines across rare and prevalent diseases.
Aurinia PharmaceuticalsAurinia is a biopharmaceutical company developing therapies for autoimmune diseases with significant unmet medical needs. The company's marketed product LUPKYNIS treats active lupus nephritis, and it is also developing aritinercept for broader autoimmune indications.
Antheia, Inc.Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing. The company targets pharmaceutical supply chains, aiming to reduce drug shortages and improve reliability for medicines traditionally derived from plants.

Companies working in the same space as Afynia.

In the news

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunchtechcrunch.com · Feb 2025

Frequently asked questions

What does Afynia do?
Afynia develops diagnostic tools focused on women's health, with an emphasis on endometriosis detection through diagnostic biomarkers. The company operates a CLIA laboratory and works on molecular biology testing for reproductive health conditions.
Who founded Afynia?
Afynia was founded by Dr. Lauren Foster, Dr. Jocelyn Wessels, Warren (Lauren) Foster, Ph.D., FCAHS.
Who are Afynia's investors?
Afynia's investors include SOSV, Gaingels, Impact America Fund.